270 related articles for article (PubMed ID: 35762211)
1.
Jimenez-Vazquez EN; Arad M; Macías Á; Vera-Pedrosa ML; Cruz FM; Gutierrez LK; Cuttitta AJ; Monteiro da Rocha A; Herron TJ; Ponce-Balbuena D; Guerrero-Serna G; Binah O; Michele DE; Jalife J
Elife; 2022 Jun; 11():. PubMed ID: 35762211
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients.
Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Shemer Y; Baskin P; Reiter I; Willi L; Freimark D; Gherghiceanu M; Monserrat L; Scherr M; Hilfiker-Kleiner D; Arad M; Michele DE; Binah O
J Cell Mol Med; 2019 Mar; 23(3):2125-2135. PubMed ID: 30618214
[TBL] [Abstract][Full Text] [Related]
3. Brugada syndrome trafficking-defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels.
Pérez-Hernández M; Matamoros M; Alfayate S; Nieto-Marín P; Utrilla RG; Tinaquero D; de Andrés R; Crespo T; Ponce-Balbuena D; Willis BC; Jiménez-Vazquez EN; Guerrero-Serna G; da Rocha AM; Campbell K; Herron TJ; Díez-Guerra FJ; Tamargo J; Jalife J; Caballero R; Delpón E
JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232268
[TBL] [Abstract][Full Text] [Related]
4. Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes.
Eisen B; Binah O
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240001
[TBL] [Abstract][Full Text] [Related]
5. Kir2.1-Na
Gutiérrez LK; Moreno-Manuel AI; Jalife J
Heart Rhythm; 2024 May; 21(5):630-646. PubMed ID: 38244712
[TBL] [Abstract][Full Text] [Related]
6. Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells.
Pioner JM; Guan X; Klaiman JM; Racca AW; Pabon L; Muskheli V; Macadangdang J; Ferrantini C; Hoopmann MR; Moritz RL; Kim DH; Tesi C; Poggesi C; Murry CE; Childers MK; Mack DL; Regnier M
Cardiovasc Res; 2020 Feb; 116(2):368-382. PubMed ID: 31049579
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Kir2.1 and Na
Ponce-Balbuena D; Guerrero-Serna G; Valdivia CR; Caballero R; Diez-Guerra FJ; Jiménez-Vázquez EN; Ramírez RJ; Monteiro da Rocha A; Herron TJ; Campbell KF; Willis BC; Alvarado FJ; Zarzoso M; Kaur K; Pérez-Hernández M; Matamoros M; Valdivia HH; Delpón E; Jalife J
Circ Res; 2018 May; 122(11):1501-1516. PubMed ID: 29514831
[TBL] [Abstract][Full Text] [Related]
8. Decreasing microtubule detyrosination modulates Nav1.5 subcellular distribution and restores sodium current in mdx cardiomyocytes.
Nasilli G; de Waal TM; Marchal GA; Bertoli G; Veldkamp MW; Rothenberg E; Casini S; Remme CA
Cardiovasc Res; 2024 May; 120(7):723-734. PubMed ID: 38395031
[TBL] [Abstract][Full Text] [Related]
9. Bioenergetic and Metabolic Impairments in Induced Pluripotent Stem Cell-Derived Cardiomyocytes Generated from Duchenne Muscular Dystrophy Patients.
Willi L; Abramovich I; Fernandez-Garcia J; Agranovich B; Shulman M; Milman H; Baskin P; Eisen B; Michele DE; Arad M; Binah O; Gottlieb E
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077200
[TBL] [Abstract][Full Text] [Related]
10. Protein assemblies of sodium and inward rectifier potassium channels control cardiac excitability and arrhythmogenesis.
Willis BC; Ponce-Balbuena D; Jalife J
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1463-73. PubMed ID: 25862830
[TBL] [Abstract][Full Text] [Related]
11. Nav1.5 N-terminal domain binding to α1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels.
Matamoros M; Pérez-Hernández M; Guerrero-Serna G; Amorós I; Barana A; Núñez M; Ponce-Balbuena D; Sacristán S; Gómez R; Tamargo J; Caballero R; Jalife J; Delpón E
Cardiovasc Res; 2016 May; 110(2):279-90. PubMed ID: 26786162
[TBL] [Abstract][Full Text] [Related]
12. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.
Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L
Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035
[TBL] [Abstract][Full Text] [Related]
13. Syncytium cell growth increases Kir2.1 contribution in human iPSC-cardiomyocytes.
Li W; Han JL; Entcheva E
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1112-H1122. PubMed ID: 32986966
[TBL] [Abstract][Full Text] [Related]
14. Reduced Na
Ebner J; Uhrin P; Szabo PL; Kiss A; Podesser BK; Todt H; Hilber K; Koenig X
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1436-H1440. PubMed ID: 32383994
[TBL] [Abstract][Full Text] [Related]
15. The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of short QT syndrome type 3.
Moreno-Manuel AI; Macías Á; Cruz FM; Gutiérrez LK; Martínez F; González-Guerra A; Martínez Carrascoso I; Bermúdez-Jimenez FJ; Sánchez-Pérez P; Vera-Pedrosa ML; Ruiz-Robles JM; Bernal JA; Jalife J
Cardiovasc Res; 2024 Apr; 120(5):490-505. PubMed ID: 38261726
[TBL] [Abstract][Full Text] [Related]
16. Depressed β-adrenergic inotropic responsiveness and intracellular calcium handling abnormalities in Duchenne Muscular Dystrophy patients' induced pluripotent stem cell-derived cardiomyocytes.
Mekies LN; Regev D; Eisen B; Fernandez-Gracia J; Baskin P; Ben Jehuda R; Shulman R; Reiter I; Palty R; Arad M; Gottlieb E; Binah O
J Cell Mol Med; 2021 Apr; 25(8):3922-3934. PubMed ID: 33619882
[TBL] [Abstract][Full Text] [Related]
17. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes.
Lee HA; Hyun SA; Byun B; Chae JH; Kim KS
PLoS One; 2018; 13(4):e0195577. PubMed ID: 29630634
[TBL] [Abstract][Full Text] [Related]
19. TRF2 rescues telomere attrition and prolongs cell survival in Duchenne muscular dystrophy cardiomyocytes derived from human iPSCs.
Eguchi A; Gonzalez AFGS; Torres-Bigio SI; Koleckar K; Birnbaum F; Zhang JZ; Wang VY; Wu JC; Artandi SE; Blau HM
Proc Natl Acad Sci U S A; 2023 Feb; 120(6):e2209967120. PubMed ID: 36719921
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated iron homeostasis in dystrophin-deficient cardiomyocytes: correction by gene editing and pharmacological treatment.
Andrysiak K; Machaj G; Priesmann D; Woźnicka O; Martyniak A; Ylla G; Krüger M; Pyza E; Potulska-Chromik A; Kostera-Pruszczyk A; Łoboda A; Stępniewski J; Dulak J
Cardiovasc Res; 2024 Feb; 120(1):69-81. PubMed ID: 38078368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
